Histone Acetylation and Cancer

Acta Oncologica

Volumn 42, Issue 7, 2003, Pages 792-

  Kouraklis, Gregory ^a,b   Theocharis, Stamos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; APICIDIN; BENZAMIDE; DEPSIPEPTIDE; FR 901228; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; OXAMFLATIN; SHORT CHAIN FATTY ACID; TETRAPEPTIDE; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT;

ACETYLATION; APOPTOSIS; CANCER; CATALYSIS; CELL DIFFERENTIATION; CLINICAL TRIAL; DEACETYLATION; DNA CONFORMATION; DNA TRANSCRIPTION; ENZYME ACTIVITY; EUKARYOTIC CELL; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; LETTER; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

ACETYLATION; HISTONES; HUMANS; NEOPLASMS;

EID: 10744231476     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310010664     Document Type: Letter

References (4)

1. Kouraklis G, Theocharis S. Histone deacetylase inhibitors and anticancer therapy. Curr Med Chem - Anti-cancer Agents 2002; 2: 477-84.
2. Zwiebel JA. New agents for acute myelogenous leukemia. Leukemia 2000; 14: 488-90.
3. Timmerman S, Lehrmann H, Popesskaya A, Harel-Bellan A. Histone acetylation and disease. Cell Mol Life Sci 2001; 58: 728-36.
4. Marks P, Rifkind R, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 2001; 1: 194-9.